Trials / Completed
CompletedNCT01801293
A Phase 1 Study to Evaluate the Pharmacokinetics, Metabolism, and Excretion of GS-5806
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Gilead Sciences · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This is a single center, open-label, Phase 1 study to determine the mass balance of of GS-5806 following administration of a single, oral dose of radiolabeled \[14C\]-GS-5806 in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GS-5806 |
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2013-04-01
- Completion
- 2013-04-01
- First posted
- 2013-02-28
- Last updated
- 2013-06-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01801293. Inclusion in this directory is not an endorsement.